Inder Paul Singh, MD, speaks to the potential of artificial intelligence (AI) in the management of the glaucoma disease state ...

Sonia H. Yoo, MD, a cornea, cataract, and refractive surgery specialist and a member of the planning committee for the ...

Andrew Iwach, MD, co-founder of the Glaucoma 360 meeting shares that value this meeting has for residents and fellows as they embark on their careers and the future additions to the meeting that will ...

John Berdahl, MD, discusses a non-surgical, non-drug treatment for glaucoma approved by the FDA in 2024. The pump uses negative pressure to lower eye pressure by an average of 39% in clinical trials, ...

Andrew Iwach, MD, shares how Glaucoma 360 got its start and how today's meeting focuses on innovation that can benefit ...

Patients commonly reported unexplained blurred or hazy vision postoperatively that requires further investigation ...

Researchers conducted a study to characterize ophthalmic adverse events associated with cosmetics and personal care products ...

This research team evaluated the effectiveness of switching patients to faricimab treatment by assessing their outcomes after ...

Patients with glaucoma who are using prostaglandin F (FP) receptor agonists to control their disease may experience ...

Himani Goyal, MD, takes glaucoma care to the next level by embracing advancements that extend beyond traditional treatment ...

Colby highlights the strides made and challenges that remain for women in ophthalmology, emphasizing the importance of ...

Results from the study assisted Notal Vision in receiving De Novo authorization from the US FDA for the SCANLY Home OCT in ...